Experimental cancer therapeutics delivered to tumors via nanoparticles could provide a safer and more effective therapy than conventional chemotherapy.
The Scientist
Most Recent
A new class of immune cell could protect against type 1 diabetes by suppressing other immune cells.
Research Associate, Perelman School of Medicine, University of Pennsylvania. Age: 27
Sorting out T-cell functional and phenotypic heterogeneity depends on studying single cells.
Viral infections of the central nervous system may trigger cytokines that induce seizures.
Researchers are using modern experimental tools to probe the mysterious molecular pathways that lead to premature labor and birth.
This month’s AACR attendees, including National Cancer Institute Director Harold Varmus, discuss new approaches to cancer research using whole genome sequencing.
Physicist-turned-oncologist Robert Austin argues that cancer is a natural consequence of our rapid evolution.
Scientists develop a gel that mimics mollusc glue to coat the insides of blood vessels.
Oncologist Jane C. Wright and physics Nobel-winner Donald Glaser have died.
Follow The Scientist
Advertisement
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
